D
Abitibi Metals Corp.
AMQ
CNSX
D
Sell
3/7/2024Upgraded
Abitibi Metals Corp. (AMQ) was upgraded to D- from E+ on 3/7/2024 due to a significant increase in the total return index, growth index and valuation index. Earnings per share increased from -$0.0015 to -$0.0013.
Abitibi Metals Corp. (AMQ) was upgraded to D- from E+ on 3/7/2024 due to a significant increase in the total return index, growth index and valuation index. Earnings per share increased from -$0.0015 to -$0.0013.
E
Sell
11/28/2023Downgrade
Abitibi Metals Corp. (AMQ) was downgraded to E+ from D- on 11/28/2023 due to a major decline in the growth index and valuation index. Earnings per share declined from -$0.0003 to -$0.0047, EBIT declined 163.93% from -$24.4 to -$64.4, and operating cash flow declined 20.21% from -$19.3 to -$23.2.
Abitibi Metals Corp. (AMQ) was downgraded to E+ from D- on 11/28/2023 due to a major decline in the growth index and valuation index. Earnings per share declined from -$0.0003 to -$0.0047, EBIT declined 163.93% from -$24.4 to -$64.4, and operating cash flow declined 20.21% from -$19.3 to -$23.2.
D
Sell
9/20/2023Upgraded
Goldseek Resources Inc. (GSK) was upgraded to D- from E+ on 9/20/2023 due to an increase in the volatility index and total return index.
Goldseek Resources Inc. (GSK) was upgraded to D- from E+ on 9/20/2023 due to an increase in the volatility index and total return index.
E
Sell
9/5/2023Downgrade
Goldseek Resources Inc. (GSK) was downgraded to E+ from D- on 9/5/2023 due to a decline in the volatility index.
Goldseek Resources Inc. (GSK) was downgraded to E+ from D- on 9/5/2023 due to a decline in the volatility index.
D
Sell
8/15/2023Upgraded
Goldseek Resources Inc. (GSK) was upgraded to D- from E+ on 8/15/2023 due to an increase in the volatility index and valuation index.
Goldseek Resources Inc. (GSK) was upgraded to D- from E+ on 8/15/2023 due to an increase in the volatility index and valuation index.
E
Sell
7/28/2023Downgrade
Goldseek Resources Inc. (GSK) was downgraded to E+ from D- on 7/28/2023 due to a decline in the volatility index, total return index and valuation index.
Goldseek Resources Inc. (GSK) was downgraded to E+ from D- on 7/28/2023 due to a decline in the volatility index, total return index and valuation index.
D
Sell
7/12/2023Upgraded
Goldseek Resources Inc. (GSK) was upgraded to D- from E+ on 7/12/2023 due to an increase in the total return index and volatility index.
Goldseek Resources Inc. (GSK) was upgraded to D- from E+ on 7/12/2023 due to an increase in the total return index and volatility index.
E
Sell
6/22/2023Downgrade
Goldseek Resources Inc. (GSK) was downgraded to E+ from D- on 6/22/2023 due to a decline in the volatility index and total return index.
Goldseek Resources Inc. (GSK) was downgraded to E+ from D- on 6/22/2023 due to a decline in the volatility index and total return index.
D
Sell
6/5/2023Upgraded
Goldseek Resources Inc. (GSK) was upgraded to D- from E+ on 6/5/2023 due to an increase in the total return index and valuation index.
Goldseek Resources Inc. (GSK) was upgraded to D- from E+ on 6/5/2023 due to an increase in the total return index and valuation index.
E
Sell
5/1/2023Downgrade
Goldseek Resources Inc. (GSK) was downgraded to E+ from D- on 5/1/2023 due to a decline in the valuation index.
Goldseek Resources Inc. (GSK) was downgraded to E+ from D- on 5/1/2023 due to a decline in the valuation index.
D
Sell
4/14/2023Upgraded
Goldseek Resources Inc. (GSK) was upgraded to D- from E+ on 4/14/2023 due to an increase in the volatility index and total return index.
Goldseek Resources Inc. (GSK) was upgraded to D- from E+ on 4/14/2023 due to an increase in the volatility index and total return index.
E
Sell
3/14/2023Downgrade
Goldseek Resources Inc. (GSK) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
Goldseek Resources Inc. (GSK) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/9/2023Upgraded
Goldseek Resources Inc. (GSK) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
Goldseek Resources Inc. (GSK) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
E
Sell
2/8/2023Downgrade
Goldseek Resources Inc. (GSK) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index.
Goldseek Resources Inc. (GSK) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index.
D
Sell
2/3/2023Downgrade
Goldseek Resources Inc. (GSK) was downgraded to D- from D on 2/3/2023 due to a decline in the volatility index.
Goldseek Resources Inc. (GSK) was downgraded to D- from D on 2/3/2023 due to a decline in the volatility index.
D
Sell
1/19/2023Upgraded
Goldseek Resources Inc. (GSK) was upgraded to D from D- on 1/19/2023 due to an increase in the volatility index.
Goldseek Resources Inc. (GSK) was upgraded to D from D- on 1/19/2023 due to an increase in the volatility index.
D
Sell
12/28/2022Downgrade
Goldseek Resources Inc. (GSK) was downgraded to D- from D on 12/28/2022 due to a decline in the volatility index.
Goldseek Resources Inc. (GSK) was downgraded to D- from D on 12/28/2022 due to a decline in the volatility index.
D
Sell
12/12/2022Upgraded
Goldseek Resources Inc. (GSK) was upgraded to D from D- on 12/12/2022 due to an increase in the growth index, valuation index and volatility index. Operating cash flow increased 341.82% from $11 to $48.6, earnings per share increased from -$0.0038 to -$0.0008, and EBIT increased 14.43% from -$19.4 to -$16.6.
Goldseek Resources Inc. (GSK) was upgraded to D from D- on 12/12/2022 due to an increase in the growth index, valuation index and volatility index. Operating cash flow increased 341.82% from $11 to $48.6, earnings per share increased from -$0.0038 to -$0.0008, and EBIT increased 14.43% from -$19.4 to -$16.6.
D
Sell
6/21/2022Downgrade
Goldseek Resources Inc. (GSK) was downgraded to D- from D on 6/21/2022 due to a decline in the volatility index, total return index and valuation index.
Goldseek Resources Inc. (GSK) was downgraded to D- from D on 6/21/2022 due to a decline in the volatility index, total return index and valuation index.
D
Sell
6/6/2022Upgraded
Goldseek Resources Inc. (GSK) was upgraded to D from D- on 6/6/2022 due to an increase in the growth index, total return index and volatility index. Operating cash flow increased 58.36% from -$291.1 to -$121.2.
Goldseek Resources Inc. (GSK) was upgraded to D from D- on 6/6/2022 due to an increase in the growth index, total return index and volatility index. Operating cash flow increased 58.36% from -$291.1 to -$121.2.
D
Sell
5/5/2022Upgraded
Goldseek Resources Inc. (GSK) was upgraded to D- from E+ on 5/5/2022 due to an increase in the volatility index, valuation index and total return index.
Goldseek Resources Inc. (GSK) was upgraded to D- from E+ on 5/5/2022 due to an increase in the volatility index, valuation index and total return index.
E
Sell
4/20/2022Downgrade
Goldseek Resources Inc. (GSK) was downgraded to E+ from D- on 4/20/2022 due to a large decline in the growth index and valuation index. Operating cash flow declined 258.29% from $183.9 to -$291.1, and earnings per share declined from $0.0014 to -$0.0009.
Goldseek Resources Inc. (GSK) was downgraded to E+ from D- on 4/20/2022 due to a large decline in the growth index and valuation index. Operating cash flow declined 258.29% from $183.9 to -$291.1, and earnings per share declined from $0.0014 to -$0.0009.
D
Sell
2/11/2022Downgrade
Goldseek Resources Inc. (GSK) was downgraded to D- from D on 2/11/2022 due to a decline in the total return index and volatility index.
Goldseek Resources Inc. (GSK) was downgraded to D- from D on 2/11/2022 due to a decline in the total return index and volatility index.
D
Sell
11/26/2021Upgraded
Goldseek Resources Inc. (GSK) was upgraded to D from D- on 11/26/2021 due to a substantial increase in the growth index. Operating cash flow increased 1,271.34% from -$15.7 to $183.9, and earnings per share increased from -$0.0032 to $0.0014.
Goldseek Resources Inc. (GSK) was upgraded to D from D- on 11/26/2021 due to a substantial increase in the growth index. Operating cash flow increased 1,271.34% from -$15.7 to $183.9, and earnings per share increased from -$0.0032 to $0.0014.
D
Sell
11/23/2021Upgraded
Goldseek Resources Inc. (GSK) was upgraded to D- from E+ on 11/23/2021 due to an increase in the total return index.
Goldseek Resources Inc. (GSK) was upgraded to D- from E+ on 11/23/2021 due to an increase in the total return index.
E
Sell
11/8/2021Downgrade
Goldseek Resources Inc. (GSK) was downgraded to E+ from D- on 11/8/2021 due to a major decline in the efficiency index, growth index and total return index. Total capital declined 4.05% from $3.22M to $3.09M.
Goldseek Resources Inc. (GSK) was downgraded to E+ from D- on 11/8/2021 due to a major decline in the efficiency index, growth index and total return index. Total capital declined 4.05% from $3.22M to $3.09M.
D
Sell
12/1/2020Upgraded
Goldseek Resources Inc. (GSK) was upgraded to D- from E on 12/1/2020 due to a major increase in the growth index, efficiency index and valuation index. Total capital increased 166.03% from $599 to $1.59M, earnings per share increased from -$0.0039 to -$0.0025, and net income increased 28.02% from -$72.8 to -$52.4.
Goldseek Resources Inc. (GSK) was upgraded to D- from E on 12/1/2020 due to a major increase in the growth index, efficiency index and valuation index. Total capital increased 166.03% from $599 to $1.59M, earnings per share increased from -$0.0039 to -$0.0025, and net income increased 28.02% from -$72.8 to -$52.4.
E
Sell
9/1/2020Upgraded
Goldseek Resources Inc. (GSK) was upgraded to E from E- on 9/1/2020 due to a large increase in the total return index.
Goldseek Resources Inc. (GSK) was upgraded to E from E- on 9/1/2020 due to a large increase in the total return index.
E
Sell
6/4/2020None
Abitibi Metals Corp. (AMQ) was downgraded to E- from U on 06/04/2020.
Abitibi Metals Corp. (AMQ) was downgraded to E- from U on 06/04/2020.
